Bone Morphogenetic Protein Receptor, Type IB, BMP Type-1B Receptor, EC 2.7.11.30, BMPR-1B, ALK6, Bone Morphogenetic Protein Receptor Type-1B, Serine/Threonine Receptor Kinase, CDw293 Antigen, EC 2.7.11, CDw293, ALK-6, Bone morphogenetic protein receptor type-1B.
Bone Morphogenetic Protein Receptor, Type IB, BMP Type-1B Receptor, EC 2.7.11.30, BMPR-1B, ALK6, Bone Morphogenetic Protein Receptor Type-1B, Serine/Threonine Receptor Kinase, CDw293 Antigen, EC 2.7.11, CDw293, ALK-6, Bone morphogenetic protein receptor type-1B.
Bone Morphogenetic Protein Receptor-1B (BMPR1B) is a member of the bone morphogenetic protein (BMP) receptor family, which belongs to the larger transforming growth factor-beta (TGF-β) superfamily. These receptors are transmembrane serine/threonine kinases that play crucial roles in various biological processes, including embryogenesis, tissue homeostasis, and disease progression .
BMPR1B is a type I receptor that forms heteromeric complexes with type II receptors to transduce BMP signals. The receptor complex typically consists of two type I and two type II receptors. Type II receptors bind BMP ligands in the absence of type I receptors, but signaling requires the presence of both receptor types . Upon ligand binding, BMPR1B undergoes phosphorylation, which activates downstream signaling pathways, including the SMAD pathway, leading to the regulation of gene expression .
BMPR1B is involved in several critical biological processes:
Mutations in the BMPR1B gene have been associated with several diseases:
Human recombinant BMPR1B is produced using recombinant DNA technology, which involves inserting the BMPR1B gene into a suitable expression system, such as bacteria or mammalian cells, to produce the protein in large quantities. This recombinant protein is used in various research and therapeutic applications to study BMP signaling pathways and to develop treatments for diseases associated with BMPR1B dysfunction .